Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Anjaparavanda Naren, PHD Role of Adenylate Cyclase 6 in Cystic Fibrosis Foundation RAMANA22H0 6/1/22-5/31/23 $1,500
John J Brewington, MD Assessing Transcription in Nas Cystic Fibrosis Foundation /Northwestern University Medical School 60055348CCH 1/1/21-12/31/21 $5,400
Raouf Samy Amin, MD Impact of treatment of mild sl National Institutes of Health (NIH)/Brigham & Women's Hospital 113047 7/1/21-6/30/22 $6,000
Christopher Siracusa, MD Qualitative Understanding of E Cystic Fibrosis Foundation /Children's Hospital Boston STRC-113-20-01 9/1/21-8/31/22 $6,542
Daniel A Ignatiuk, MD ATS ASPIRE Fellowship Program American Thoracic Society ATS_ASPIRE 7/1/21-6/30/22 $10,000
Erik B Hysinger, MD Implementation of Effective Ho Patient-Centered Outcome Research Inst./Univ of Massachusetts Medical School OSP33393-03 2/1/21-1/31/22 $16,373
Christopher Siracusa, MD Success with Therapies Researc Cystic Fibrosis Foundation SIRACU15PEO 8/1/21-7/31/22 $34,720
John J Brewington, MD Personalized Model Systems to Cystic Fibrosis Foundation CFF_Brewington 8/1/21-7/31/22 $50,000
Elizabeth L Kramer, MD-PHD TGF-Beta Regulates CFTR-Mediat Cystic Fibrosis Foundation KRAMER21A0-KB 2/1/21-1/31/22 $50,000
Laura L Walkup, PHD Hyperpolarzied 129Xe gas MRI t University of Cincinnati Cancer Center UCCC - Walkup,Laura 5/1/22-4/30/24 $50,000
William D Hardie, MD Cincinnati Children's Summer M National Institutes of Health (NIH) T35HL113229 5/1/22-4/30/23 $61,694
Steven J Rose, DO 1st and 2nd Year Clinical Fell Cystic Fibrosis Foundation ROSE21B0 7/1/21-6/30/22 $62,000
Melanie A Anderson, MD 1st and 2nd Year Clinical Fell Cystic Fibrosis Foundation KAPLAN21B0 7/1/21-6/30/22 $62,000
Carolyn Dress, MD First and Second Year Clinical Cystic Fibrosis Foundation DRESS20B0 7/1/21-6/30/22 $67,000
Stacey Ishman, MD-MPH Positive airway pressure for t National Institutes of Health (NIH)/Children's Hospital of Philadelphia 3201930820 9/1/20-8/31/21 $68,901
Nara S Higano, PHD Neonatal pulmonary ventilation Francis Family Foundation FBP_Higano 7/1/21-6/30/22 $75,000
Stacey Ishman, MD-MPH Velopharyngeal insufficiency f National Institutes of Health (NIH)/Phoenix Children's Hospital SITZMAN-20-03 7/1/21-6/30/22 $75,186
Benjamin L Wisniewski, MD Evaluating The Effect of Sleep Cystic Fibrosis Foundation WISNIE21D0 7/1/21-6/30/22 $80,000
Raouf Samy Amin, MD Seattle - A prospective study Cystic Fibrosis Foundation /Seattle Children's PROMISE-OB-18 3/28/19-3/27/23 $92,148
Duncan E Keegan, MD 3rd Year Clinical Fellowship G Cystic Fibrosis Foundation TBD 7/1/21-6/30/22 $100,000
Michael Seid, PHD Asthma Learning Health System Luther Foundation Luther Fou - Seid,Mi 11/17/21-11/16/22 $100,000
Gary McPhail, MD Rare CFTR Mutation Cell Collection Protocol Cystic Fibrosis Fdn Therapeutics, Inc RARE OB-16 1/1/20-6/30/23 $106,946
Thomas F Boat, MD RESPONDING TO EDUCATIONAL NEED Cystic Fibrosis Foundation BOAT21QIO 6/1/21-5/31/22 $107,362
Gary McPhail, MD Therapeutic Development Center Cystic Fibrosis Foundation CLANCY14Y0 4/1/21-3/31/22 $117,930
Sheharyar Durrani, MD Non-inferiority study of GSK35 IQVIA RDS, Inc IQVIA- Durrani 8/24/21-8/23/24 $123,026
Sheharyar Durrani, MD Placebo-controlled efficacy an IQVIA RDS, Inc GSK3511294 8/3/21-8/2/26 $133,985
John J Brewington, MD Personalized Model Systems to National Institutes of Health (NIH) K08HL144825 8/1/21-7/31/22 $163,620
Elizabeth L Kramer, MD-PHD TGF-Beta Regulates CFTR-Mediat National Institutes of Health (NIH) KHL151762A 2/1/22-1/31/23 $164,160
Gary McPhail, MD Therapeutics Development Cente Cystic Fibrosis Foundation MCPHAI22Y0 4/1/22-3/31/23 $167,023
John J Brewington, MD Nasal Cell Theratyping Advance Cystic Fibrosis Foundation CFF_Brewington_Outco 4/1/21-3/31/22 $168,000
Theresa Guilbert, MD-MS ORBEX: Primary Prevention of Asthma and Wheezing in Children National Institutes of Health (NIH)/University of Arizona PO 438886 5/1/20-4/30/21 $186,563
Zackary Cleveland, PHD Using MRI to visualize regiona National Institutes of Health (NIH)/Duke University A034671 4/10/21-3/31/22 $188,719
Christopher Siracusa, MD Cystic Fibrosis Center Cystic Fibrosis Foundation 000734CC320 7/1/21-6/30/22 $194,340
Jeffrey A Whitsett, MD Pulmonary Development and Dise National Institutes of Health (NIH) T32HL007752 7/1/21-6/30/22 $232,681.33
Laura L Walkup, PHD Early detection of regional BO National Institutes of Health (NIH) R00HL138255 4/1/22-3/31/23 $249,000
Alister J Bates Improving Outcomes in Pediatri National Institutes of Health (NIH) R00HL144822 1/1/22-12/31/22 $249,000
Nathan M Pajor, MD Describing ventilator weaning Children's Hospital of Philadelphia 3201350921 PO 202691 9/30/21-9/29/22 $262,711
Christine Heubi, MD Positive airway pressure for t National Institutes of Health (NIH)/Children's Hospital of Philadelphia GRT-00001521 9/1/21-8/31/22 $278,974
Christine Heubi, MD Positive airway pressure for t National Institutes of Health (NIH)/Children's Hospital of Philadelphia GRT-00001521/PO# 202 9/1/21-8/31/22 $278,974
Theresa Guilbert, MD-MS ORBEX: Primary Prevention of Asthma and Wheezing in Children National Institutes of Health (NIH)/University of Arizona PO 438886 5/1/20-4/30/21 $279,247
Nathan M Pajor, MD The RECOVER Post-Acute Sequela National Institutes of Health (NIH)/Children's Hospital of Philadelphia OT2HL161847 10/1/21-5/23/25 $286,200
Jason C Woods, PHD Hyperpolarized Imaging for New Cystic Fibrosis Foundation CFF Woods 8/1/21-7/31/22 $356,674
Raouf Samy Amin, MD Pulmonary Vascular Disease in Cystic Fibrosis Foundation AMIN19A0 1/1/22-12/31/22 $368,628
Satish K Madala, PHD WT1 Regulation of Pulmonary Fibrosis National Institutes of Health (NIH) R01HL134801 5/1/21-4/30/22 $389,919
Satish K Madala, PHD WT1 REGULATION OF PULMONARY FI National Institutes of Health (NIH) R01HL134801 5/6/22-4/30/23 $530,280
Zackary Cleveland, PHD Imaging and Molecular Phenotyp National Institutes of Health (NIH) RHL151588A 2/1/22-1/31/23 $562,685
Raouf Samy Amin, MD Personalizing Cystic Fibrosis Cystic Fibrosis Foundation Naren19R0 7/1/21-6/30/22 $600,002
Zackary Cleveland, PHD Validating Quantitative Magnet National Institutes of Health (NIH) R01HL143011 1/1/22-12/31/22 $675,963
Stella M Davies, MD TRANSPIRE: A Prospective Cohor National Institutes of Health (NIH) 1R01HL157392-01 9/1/21-5/31/22 $742,257
Jason C Woods, PHD BEGIN Novel ImagiNG Biomarkers Cystic Fibrosis Foundation WOODS21K0 8/1/21-7/31/22 $744,398
Satish K Madala, PHD Sox9 Regulation of Fibroblast National Institutes of Health (NIH) RHL157176A 6/1/22-5/31/23 $1,069,940
Anjaparavanda Naren, PHD Personalized Cystic Fibrosis T National Institutes of Health (NIH) P30DK117467 7/1/21-6/30/22 $1,263,344
Michael Seid, PHD CF Learning Network: Implementation Phase 2020 Cystic Fibrosis Foundation SEID19AB0 1/1/22-12/31/22 $3,009,161
Total Annual Grant Award Dollars $15,326,176.33

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Sheharyar Durrani, MD Regeneron Pharmaceuticals, Inc. $105,321
Sheharyar Durrani, MD Astrazeneca $136,675
Thomas F Boat, MD Vertex Pharmaceutical Incorporated $189,875
Total Annual Industry Award Dollars $431,871